immunochromatograph
test
strip
ict
detect
antibodi
rabi
viru
develop
use
colloid
gold
particl
label
rabi
viru
glycoprotein
tracer
assay
evalu
use
sera
dog
immun
variou
commerci
rabi
vaccin
dog
clinic
sera
dog
immun
vaccin
pathogen
rabi
viru
neg
sera
wide
varieti
anim
sourc
includ
dog
mice
cat
never
vaccin
ict
found
highli
specif
antibodi
rabi
viru
detect
limit
iuml
measur
fluoresc
antibodi
viru
neutral
favn
test
compar
favn
test
specif
sensit
ict
respect
excel
agreement
result
obtain
ict
favn
test
kappa
strip
store
c
plastic
bag
desicc
retain
specif
sensit
least
month
strip
store
ambient
temperatur
remain
stabl
month
immunochromatograph
test
strip
may
therefor
use
clinic
laboratori
lack
special
equip
diagnosi
field
rapid
detect
rabi
virusspecif
antibodi
measur
seroneutr
antibodi
use
commonli
mani
year
assess
level
immun
rabi
aubert
cliquet
et
al
virusneutr
antibodi
titer
iuml
sera
threshold
seroconvers
rabi
vaccin
recommend
world
health
organ
detect
quantit
antibodi
rabi
viru
rabv
also
prime
import
assess
efficaci
rabi
vaccin
campaign
rapid
fluoresc
focu
inhibit
test
rffit
smith
et
al
fluoresc
antibodi
viru
neutral
favn
test
cliquet
et
al
vitro
method
recommend
world
organ
anim
health
oie
measur
viru
neutral
antibodi
howev
assay
requir
consider
level
expertis
gener
undertaken
refer
laboratori
suitabl
biocontain
facil
addit
procedur
timeconsum
limit
number
sampl
process
one
time
therefor
ineffici
expens
human
anim
clinic
develop
countri
without
train
personnel
challeng
centuri
diagnost
test
develop
twofold
first
achiev
intern
accept
valid
test
second
overcom
financi
logist
barrier
prevent
implement
test
develop
countri
greatest
need
fook
et
al
conveni
afford
diagnost
test
antibodi
rabi
viru
develop
countri
rabi
endem
resourc
limit
immunochromatograph
assay
also
refer
later
flow
devic
simpli
strip
assay
techniqu
cellulos
membran
use
carrier
colloid
goldlabel
antigen
antibodi
use
tracer
zhang
et
al
zhang
et
al
although
method
use
qualit
analysi
far
provid
rapid
detect
antigen
antibodi
thu
possess
advantag
convent
immunoassay
low
cost
inexpens
equip
simplic
procedur
rapid
oper
longterm
stabil
wide
rang
environment
condit
characterist
render
test
ideal
suit
onsit
test
untrain
personnel
peng
et
al
immunogold
label
appli
see
front
matter
elsevi
bv
right
reserv
wide
diagnosi
infect
antibodi
detect
cui
et
al
hedstrom
et
al
mikawa
et
al
oku
et
al
smit
et
al
yang
et
al
rapid
immunochromatograph
test
kit
rabi
viru
detect
develop
evalu
use
clinic
sampl
kit
provid
simpl
rapid
method
detect
infect
rabi
kang
et
al
nishizono
et
al
present
studi
rapid
onestep
immunochromatograph
test
strip
capabl
detect
specif
rabi
viru
antibodi
serum
develop
mous
neuroblastoma
mna
cell
maintain
rpmi
mediatech
herndon
va
supplement
fetal
bovin
serum
fb
gibco
grand
island
ny
challeng
viru
standard
strain
rabv
propag
mna
cell
chloroaur
acid
purchas
sigma
compani
st
loui
mo
usa
nitrocellulos
membran
fiberglass
filter
paper
purchas
millipor
corpor
billerica
usa
fluorescein
isothiocyan
fitc
conjug
antibodi
rabi
viral
n
protein
purchas
fujirebio
melvin
pa
mous
monoclon
antibodi
recogn
epitop
antigen
site
ii
rabv
g
protein
select
militari
institut
veterinari
scienc
changchun
neutral
potenc
antibodi
iuml
mgml
rabi
viru
detect
favn
test
antisera
canin
distemp
viru
cdv
canin
parvoviru
cpv
canin
adenoviru
cavi
canin
parainfluenza
viru
cpiv
canin
coronaviru
ccv
rabi
viru
prepar
militari
institut
veterinari
scienc
changchun
sera
dog
cat
rabbit
mice
never
vaccin
use
neg
control
anim
hous
handl
follow
ethic
guidelin
regul
anim
ethic
welfar
militari
institut
veterinari
scienc
academi
militari
medic
scienc
china
total
clinic
sera
collect
random
differ
provinc
evalu
serum
sampl
store
c
use
rabi
viru
glycoprotein
rabv
g
prepar
modif
techniqu
describ
previous
barton
campbel
cox
et
al
smith
et
al
mna
cell
infect
multipl
infect
moi
incub
c
cultur
fluid
collect
cell
remov
centrifug
g
min
c
viru
pellet
ultracentrifug
g
h
c
pellet
resuspend
pb
left
overnight
c
betapropiolacton
bpl
sigma
inc
ad
viru
solut
final
bpl
dilut
incub
continu
overnight
c
follow
h
c
permit
complet
hydrolysi
remain
bpl
inactiv
viru
layer
sucros
gradient
pellet
ultracentrifug
g
min
c
pellet
viru
resuspend
trisbuff
salin
contain
edta
tri
ph
edta
glycoprotein
dissoci
viru
incub
h
c
triton
trisbuff
salin
solubl
g
protein
fraction
separ
residu
suspens
sediment
latter
sucros
cushion
g
min
collect
aspir
layer
cushion
dialysi
phosphat
buffer
pb
mm
ph
sephadex
ge
healthcar
uk
filtrat
use
remov
excess
ampholin
g
protein
dialyz
extens
phosphat
buffer
pb
mm
ph
store
aliquot
c
use
protein
concentr
determin
use
bca
kit
pierc
inc
rockford
il
purifi
rabi
viru
glycoprotein
analyz
immunoblot
analysi
g
solubl
protein
eletrophores
denatur
gel
transfer
polyvinyliden
difluorid
membran
biorad
usa
membran
block
h
room
temperatur
nonfat
dri
milk
nfdm
pb
ph
follow
three
wash
pbst
pb
contain
incub
antirabv
g
monoclon
antibodi
h
c
three
addit
wash
pbst
membran
incub
hrpconjug
antimous
igg
ge
healthcar
uk
dilut
pbst
h
room
temperatur
membran
wash
three
time
pbst
develop
hrp
color
develop
kit
biorad
usa
per
manufactur
instruct
colloid
gold
particl
mean
diamet
nm
prepar
use
method
describ
previous
peng
et
al
constant
stir
ml
trisodium
citrat
wv
ad
rapidli
ml
haucl
solut
wv
c
boil
min
result
colloid
gold
cool
gradual
ambient
temperatur
continu
stir
ph
maintain
potassium
carbon
sodium
azid
ad
final
concentr
wv
storag
c
dark
color
glass
vessel
prepar
colloid
goldrabv
g
ml
purifi
g
protein
mgml
ad
ml
gold
colloid
solut
constant
stir
incub
min
room
temperatur
bovin
serum
albumin
bsa
ad
final
concentr
wv
stabil
conjug
solut
centrifug
g
min
c
wash
twice
bsa
colloid
goldrabv
g
particul
suspend
ml
mm
pb
ph
contain
bsa
sucros
wv
sodium
azid
dispens
onto
fiberglass
strip
cm
cm
billerica
usa
speed
lcm
use
xyz
dispens
platform
biodot
irvin
ca
usa
produc
conjug
pad
dri
vacuum
c
pad
seal
desicc
plastic
bag
store
c
cm
nitrocellulos
membran
cm
cm
millipor
differ
work
concentr
staphylococc
protein
spa
sigmaaldrich
st
loui
mo
usa
affinitypurifi
antirabv
g
monoclon
antibodi
dispens
test
control
line
use
dispens
platform
lcm
dri
room
temperatur
store
c
describ
sampl
fiberglass
pad
treat
mm
phosphat
buffer
contain
peg
sodium
azid
ph
dri
c
fig
provid
schemat
diagram
test
strip
prepar
cm
cm
adhes
support
board
upon
layer
mm
overlap
posit
fiberglass
sampl
pad
fiberglass
conjug
pad
nitrocellulos
membran
absorpt
pad
assembl
board
cut
mm
wide
piec
use
cm
cutter
biodot
strip
product
mount
plastic
cassett
window
sampl
pad
nitrocellulos
membran
jincanhua
industri
ltd
shenzhen
china
cassett
packag
plastic
bag
desicc
store
c
use
serum
sampl
l
appli
sampl
pad
migrat
conjug
pad
rabvspecif
antibodi
react
colloid
goldrabv
g
form
complex
diffus
across
nitrocellulos
membran
react
spa
immobil
membran
form
redpurpl
line
test
line
unreact
goldrabv
g
complex
migrat
react
antirabv
g
monoclon
antibodi
form
anoth
redpurpl
line
control
line
test
take
min
complet
sampl
viru
neutral
antibodi
titer
iuml
produc
two
redpurpl
band
test
control
line
wherea
sampl
titer
iuml
neg
rabi
viru
produc
one
band
control
line
fig
clearli
visibl
redpurpl
band
must
appear
control
line
test
valid
viru
neutral
antibodi
titer
measur
favn
test
describ
cliquet
et
al
serial
threefold
dilut
test
serum
sampl
control
prepar
micropl
well
l
volum
tcid
l
ad
well
incub
c
min
mna
cell
cell
l
ad
well
plate
incub
c
h
well
fix
icecold
aceton
stain
fitcconjug
antirabv
n
antibodi
h
plate
cell
examin
fluoresc
microscop
olympu
corpor
tokyo
japan
absenc
presenc
fluoresc
foci
cell
record
endpoint
antibodi
calcul
accord
formula
spearman
valu
compar
refer
serum
nation
institut
biolog
standard
control
hert
uk
normal
intern
unit
iuml
found
rabi
viru
g
protein
could
isol
triton
rabi
viru
without
lose
biolog
serolog
properti
atanasiu
et
al
atanasiu
et
al
cox
et
al
smith
et
al
studi
inactiv
rabi
viru
purifi
sucros
gradient
centrifug
solubl
glycoprotein
dissoci
viru
incub
triton
purifi
sucros
centrifug
sephadex
filtrat
total
protein
recov
purif
character
purifi
protein
puriti
biolog
activ
rabi
viru
g
protein
analyz
sdspage
fig
western
blot
fig
shown
fig
purifi
protein
display
domin
protein
band
repres
approxim
purifi
protein
western
blot
use
antirabv
g
monoclon
antibodi
identifi
purifi
rabi
viru
g
protein
data
show
rabi
viru
g
protein
purifi
highli
degrad
purif
procedur
staphylococc
protein
spa
affinitypurifi
antirabv
g
monoclon
antibodi
dilut
mgml
mm
pb
ph
variou
work
concentr
dispens
onto
nitrocellulos
membran
assembl
ict
optim
concentr
spa
achiev
test
ict
differ
concentr
iuml
standard
serum
select
minimum
concentr
produc
detect
line
result
show
optim
concentr
spa
produc
detect
line
iuml
standard
serum
react
sera
viru
neutral
antibodi
titer
iuml
neg
sera
mgml
optim
concentr
antirabv
g
monoclon
antibodi
determin
base
red
color
control
line
posit
neg
sampl
final
optim
concentr
spa
affinitypurifi
antirabv
g
monoclon
antibodi
immobil
mgml
respect
data
shown
specif
ict
demonstr
test
sera
dog
cat
rabbit
mice
never
vaccin
differ
serum
sampl
deriv
dog
vaccin
nonrabv
pathogen
cdv
cpv
cav
ccv
cpiv
differ
commerci
rabi
vaccin
viru
strain
maintain
laboratori
result
compar
sampl
analyz
favn
test
serum
sampl
deriv
nonimmun
dog
cat
rabbit
mice
sera
dog
immun
pathogen
rabi
viru
found
neg
antirabv
antibodi
ict
favn
test
visual
test
sampl
appear
ident
blank
control
one
redpurpl
band
control
line
serum
sampl
dog
viru
neutral
antibodi
titer
iuml
determin
favn
test
produc
two
band
ict
fig
ict
specif
sera
posit
rabi
viru
crossreact
anim
sera
sera
anim
immun
pathogen
sera
posit
rabi
viru
dog
immun
variou
rabi
vaccin
test
ict
differ
oper
viru
neutral
antibodi
titer
serum
sampl
iuml
determin
favn
test
result
ict
posit
result
neg
ict
serum
sampl
neg
titer
iuml
tabl
sensit
ict
also
demonstr
test
select
serum
sampl
titer
rang
iuml
iuml
determin
favn
test
tabl
result
show
sera
titer
iuml
produc
distinct
band
test
line
gave
neg
respons
sera
give
neg
result
vna
titer
rang
iuml
iuml
total
clinic
serum
sampl
select
random
differ
provinc
test
ict
result
tabl
total
serum
sampl
neg
sampl
determin
favn
test
also
confirm
neg
ict
sera
viru
neutral
antibodi
titer
iuml
sera
neg
ict
consist
sera
conflict
result
two
test
favn
titer
rang
iuml
iuml
sera
viru
neutral
antibodi
titer
iuml
sera
posit
ict
consist
excel
agreement
kappa
ict
favn
test
immunochromatograph
strip
packag
plastic
bag
desicc
store
c
ambient
temperatur
vari
time
month
test
specif
sensit
test
result
ident
use
strip
store
month
known
seraposit
sampl
posit
known
vnaneg
sera
neg
month
storag
ambient
temperatur
sensit
strip
decreas
slightli
known
posit
titer
iuml
produc
neg
result
howev
sera
vna
titer
iuml
iuml
neg
sera
still
test
consist
favn
test
strip
store
c
month
gave
consist
result
except
rang
iuml
test
neg
sampl
test
strip
three
separ
batch
show
complet
reproduc
batch
month
ict
store
either
c
ambient
temperatur
show
appear
dehumidifi
properli
therefor
result
show
seal
strip
could
store
least
month
c
month
ambient
temperatur
slight
loss
sensit
present
studi
describ
new
approach
determin
virusneutr
antibodi
rabi
viru
ict
techniqu
use
detect
mani
antigen
virusspecif
antibodi
cutoff
valu
ict
iuml
favn
test
use
refer
test
ict
high
specif
sensit
excel
agreement
result
obtain
favn
test
ict
kappa
clinic
sampl
sensit
specif
ict
depend
larg
antigen
use
test
strip
rabi
viru
glycoprotein
structur
protein
viru
induc
format
virusneutr
antibodi
confer
immun
anim
protect
activ
shown
associ
g
protein
membran
associ
protein
p
although
contain
residu
trace
g
protein
cox
et
al
competit
elisa
util
cell
line
stabli
express
rabi
viru
g
protein
coat
antigen
higher
specif
sensit
elisa
base
whole
rabi
viru
antigen
bahloul
et
al
servat
cliquet
also
excel
agreement
favn
test
competit
elisa
studi
present
viru
cultur
c
suffici
obtain
g
protein
viru
grown
c
order
reduc
falseposit
result
sucros
gradient
centrifug
use
purifi
viru
subsequ
g
protein
dissoci
purifi
viru
incub
triton
could
higher
biolog
protect
activ
solubil
deoxychol
nonidet
cox
et
al
sensit
specif
ict
studi
produc
differ
serum
sampl
deriv
dog
vaccin
inactiv
pasteur
viru
pv
strain
inactiv
evelynrokitnickiabelseth
era
strain
flurylep
vaccin
commerci
vaccin
intervet
nobivac
tabl
also
excel
correl
favn
test
might
attribut
use
strain
rabv
antigen
ict
favn
test
staphylococc
protein
spa
bacteri
protein
bind
high
specif
mammalian
immunoglobulin
use
commonli
purifi
immobil
detect
immunoglobulin
howev
differ
affin
immunoglobulin
differ
isotyp
also
bind
capac
immunoglobulin
spa
differ
mammalian
speci
studi
spa
immobil
membran
use
test
line
show
high
affin
serum
sampl
dog
addit
ict
also
use
detect
serum
sampl
posit
rabi
viru
deriv
human
cat
rabbit
mice
sensit
vari
data
shown
ict
show
higher
sensit
detect
sera
canin
human
rabbit
rel
lower
sensit
detect
mous
cat
sera
therefor
ict
may
also
use
serosurveil
speci
ict
valid
compar
result
clinic
serum
sampl
obtain
use
favn
test
falseneg
result
occur
ict
test
sampl
possess
viru
neutral
antibodi
iuml
impli
sera
adequ
level
neutral
antibodi
isotyp
rabvspecif
antibodi
serum
sampl
detect
elisa
shown
isotyp
antibodi
igm
igg
data
shown
sinc
spa
higher
bind
affin
igg
igm
may
explain
sampl
produc
posit
result
test
ict
among
sampl
viru
neutral
antibodi
titer
iuml
sampl
posit
ict
howev
viru
neutral
antibodi
titer
sampl
rang
iuml
sera
deriv
subject
unvaccin
receiv
vaccin
cdv
cpv
cav
ccv
cpiv
show
falseposit
result
test
ict
result
indic
ict
specif
sera
rabi
viru
date
elisa
competit
elisa
celisa
develop
test
serum
sampl
compar
result
rffit
favn
test
bahloul
et
al
cliquet
et
al
muhamuda
et
al
servat
cliquet
servat
et
al
zhang
et
al
b
method
simpl
rapid
clinic
use
howev
still
suitabl
use
outsid
research
laboratori
requir
special
equip
micropl
reader
incub
rapid
neutral
antibodi
rapina
test
describ
quantit
measur
neutral
antibodi
rabi
viru
shiota
et
al
method
serum
incub
inactiv
rabi
viru
use
rabv
g
detect
kit
base
principl
immunochromatographi
describ
previous
nishizono
et
al
comparison
elisa
rapina
advantag
conveni
safeti
rapid
special
equip
cultur
cell
live
viru
train
oper
need
result
easi
read
sera
viru
neutral
antibodi
titer
iuml
could
neutral
rabi
viru
would
produc
test
line
howev
sera
titer
iuml
would
inhibit
band
format
test
line
detect
rabv
g
detect
kit
ict
l
serum
sampl
appli
test
two
redpurpl
line
membran
indic
serum
sampl
possess
viru
neutral
antibodi
titer
iuml
one
line
appear
control
locat
serum
sampl
neg
rabi
viru
viru
neutral
antibodi
titer
iuml
also
stronger
test
line
appear
viru
specif
antibodi
present
sampl
point
one
disadvantag
ict
intens
test
line
could
reach
plateau
test
serum
sampl
titer
higher
iuml
amount
colloid
goldrabv
g
dispens
onto
fiberglass
staphylococc
protein
immobil
membran
constant
even
though
viru
neutral
antibodi
present
sampl
colloid
goldrabv
grabv
antibodi
complex
trap
staphylococc
protein
immobil
test
line
limit
color
becom
stronger
case
serum
sampl
dilut
conclus
ict
use
method
quantit
analysi
viru
neutral
antibodi
rabv
serum
differenti
anim
adequ
immun
without
adequ
immun
use
virtual
anywherelaboratori
offic
field
also
adapt
test
clinic
sampl
could
use
tool
surveil
rabi
field
vaccin
efficaci
test
sinc
bind
capac
immunoglobulin
staphylococc
protein
differ
mammalian
speci
method
could
modifi
detect
sera
deriv
human
mammal
